CEBPA, CCAAT/enhancer binding protein alpha (C/EBPα), was predicted shared in both RA and T2D as another upstream regulator, to control the activity of ARG1, MPO, MT2A and LTF downstream. Here, MT2A is linked to rheumatoid arthritis.